chr16-90009417-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001042610.3(DBNDD1):āc.45G>Cā(p.Glu15Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000472 in 1,611,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001042610.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DBNDD1 | NM_001042610.3 | c.45G>C | p.Glu15Asp | missense_variant | 2/4 | ENST00000002501.11 | NP_001036075.1 | |
DBNDD1 | NM_024043.4 | c.105G>C | p.Glu35Asp | missense_variant | 2/4 | NP_076948.2 | ||
DBNDD1 | NM_001288708.2 | c.45G>C | p.Glu15Asp | missense_variant | 3/5 | NP_001275637.1 | ||
DBNDD1 | NM_001288709.2 | c.-202G>C | 5_prime_UTR_variant | 2/4 | NP_001275638.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247436Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134530
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1459460Hom.: 0 Cov.: 31 AF XY: 0.0000482 AC XY: 35AN XY: 726066
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.105G>C (p.E35D) alteration is located in exon 2 (coding exon 2) of the DBNDD1 gene. This alteration results from a G to C substitution at nucleotide position 105, causing the glutamic acid (E) at amino acid position 35 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at